Retifanlimab (Anti-PDCD1 / PD-1 / CD279)

Retifanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of gastroesophageal adenocarcinoma (GEA). MW :145.64 KD.
Supplier Selleck Chemicals
Product # A3037
Sku # A3037-1mg*5
Pricing 1mg*5, $970.00
Feedback